1. Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial. Issue 2 (2nd October 2008) Authors: Kruis, W; Kiudelis, G; Rácz, I; Gorelov, I A; Pokrotnieks, J; Horynski, M; Batovsky, M; Kykal, J; Boehm, S; Greinwald, R; Mueller, R Journal: Gut Issue: Volume 58:Issue 2(2009) Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P492 Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for ulcerative colitis: A Phase 3, randomized, placebo-controlled study: Results of the LIBERTY-UC study. (30th January 2023) Authors: Sands, B E; Hanauer, S B; Colombel, J F; Sandborn, W; Schreiber, S; Danese, S; Klopocka, M; Kulynych, R; Kierkus, J; Soltysiak, A; Smolinski, P; Gonciarz, M; Sreckovic, S; Valuyskikh, E; Horynski, M; Gasbarrini, A; Kim, S; Bae, Y; Lee, S; Lee, J H Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P588 Interim results from the randomised VERDICT trial to determine the optimal treatment target in patients with ulcerative colitis. (30th January 2023) Authors: Jairath, V; Zou, G; Wang, Z; Adsul, S; Colombel, J F; D'Haens, G R; Freire, M; Moran, G W; Peyrin-Biroulet, L; Sandborn, W J; Sebastian, S; Travis, S; Vermeire, S; Radulescu, G; Sigler, J; Mcfarlane, S; Arya, N; Beaton, M; Bossuyt, P; Green, D Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i716 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗